Reports Q1 revenue $21.4B, consensus $21.4B. “Johnson & Johnson’s solid first quarter performance reflects our sharpened focus and the progress in our portfolio and pipeline,” said Joaquin Duato, Chairman and Chief Executive Officer. “Our impact across the full spectrum of healthcare is unique in our industry, and the milestones achieved this quarter reinforce our position as an innovation powerhouse.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Options Volatility and Implied Earnings Moves This Week, April 15 – April 19, 2024
- Integer upgraded to Buy from Neutral at BofA
- JNJ Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Buy/Sell: Wall Street’s top 10 stock calls this week
- DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls
